Kapa Baits for metagenomic sequencing
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Food and Drug Administration (FDA), under the Department of Health and Human Services, has issued a Special Notice (Notice of Intent to Sole Source) to procure myBaits® Custom 480K hybridization capture reagents for targeted metagenomic sequencing. The FDA intends to award a firm-fixed-price purchase order to Arbor Biosciences for these reagents, which are essential for detecting and identifying arthropod contaminants in food products. Interested parties who believe they can provide an equivalent product must submit capability statements by March 19, 2026, at 12:00 PM EST.
Scope of Work
This requirement is for approximately sixty-four (64) enrichment reactions of myBaits® Custom hybridization capture reagents. These reagents will support specialized FDA laboratory research in the Wiley Building (CPK1), College Park, MD, under cGMP/cGLP standards. The reagents must be equivalent to Arbor Biosciences' proprietary product and meet the Government's technical requirements for targeted metagenomic DNA sequencing.
Contract & Timeline
- Contract Opportunity Type: Special Notice (Notice of Intent to Sole Source)
- Procurement Method: FAR Part 13, Simplified Acquisition Procedures
- Product Service Code (PSC): 6640 – Laboratory Equipment And Supplies
- NAICS Code: 325414 – Biological Product (except Diagnostic) Manufacturing
- Response Due: March 19, 2026, 12:00 PM EST
- Published Date: March 12, 2026
- Place of Performance: College Park, MD
Submission & Evaluation
This notice is not a request for competitive quotes. However, interested parties who believe they can provide an equivalent product meeting the technical requirements may submit capability statements. Responses must be sent via email to Erika Crawford (Erika.Crawford@fda.hhs.gov). Submissions must include:
- Unique Entity Identification (UEI) Number
- Company Name and contact information
- Type of company (e.g., Small Business, 8(a), WOSB, HUBZone, SDVOSB)
- Evidence of capability to provide an equivalent product. Information received will be used to determine if a competitive procurement is warranted.
Eligibility / Set-Aside
- Set-Aside: None specified (Notice of Intent to Sole Source)
- Small businesses are encouraged to identify their interests and capabilities.
- All interested parties must be registered in SAM.gov.
Additional Notes
The FDA believes Arbor Biosciences is the only responsible source capable of providing the required reagents. Responses sent via means other than email to the specified Contract Specialist will not be considered.